Other
Mitochondria
0
Pipeline Programs↗
4
Active Trials↗
2
Companies Involved↗
Mitochondria is an early-stage landscape with 0 programs across 2 companies. The most active players are Minovia Therapeutics Ltd., PTC Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
21
clinical trials
Completed12 · 57%
Recruiting3 · 14%
Terminated2 · 10%
Not yet recruiting1 · 5%
Unknown status1 · 5%
No longer available1 · 5%
Other1 · 5%
Clinical Trials
Trial Activity
21 trials
Quantifying Hepatic Mitochondrial Fluxes in Humans
Recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 4·NCT05305287·60 enrolled
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
Completed·—·N/A·NCT01702987·22 enrolled
Mitochondrial Function in Septic Patients
Completed·—·N/A·NCT03748537·20 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)